down-arrowleft-arrowright-arrow

Sandy Kuzmich Partner

With practical experience in the pharmaceutical sector, together with expertise in patent procurement and defense, Dr. Kuzmich appreciates and strategically manages the complex intellectual property issues that are critical to pharmaceutical and biotechnology clients.

LOCATION

New York City

+1.212.588.0800

745 Fifth Avenue, 10th Floor,
New York, NY 10151

VIEW IN MAPS
  • Dr. Kuzmich serves as the co-chair of the firm’s Life Sciences practice group. Her practice focuses on patent litigation and strategic intellectual property counseling in the areas of pharmaceuticals, chemicals, and biotechnology. Recognizing that product life-cycle management is continuous and dynamic, she develops, manages, and protects diverse patent portfolios, taking into consideration a client’s immediate and long-term business objectives. Her extensive experience in pharmaceutical patent litigation allows her to offer a distinctive approach to protecting and maximizing the value of intellectual property assets. She specializes in counseling clients on how to obtain strong and diverse intellectual property protection on pharmaceuticals and biological products during early research, and how to expand and defend that protection throughout development, product launch, and beyond.
  • Upon completion of her graduate degree in pharmacology, Dr. Kuzmich became a post-doctoral research associate with the Fox Chase Cancer Center where she investigated mechanisms of anti-cancer drug resistance. She spent several years in the private pharmaceutical sector, managing departments in the U.S. in the areas of drug metabolism and pharmacokinetics, and also collaborating with Asian and European counterparts to coordinate worldwide regulatory submissions.
  • Dr. Kuzmich serves on the Board of Directors for the Federal Circuit Bar Association, which includes being a frequent lecturer at various international conferences throughout the year.
  • Bayer Healthcare LLC v. Baxalta Incorporated, Baxalta US Inc., and Nektar Therapeutics, No. 16-01122 (D. Del.)
  • Shire Development LLC, et al. v. Lupin Limited, et al., No. 16-612 (D. Md.)
  • Supernus Pharmaceuticals, Inc. v. Actavis, Inc., et al., No. 14-06102 (D.N.J.)
  • Shire LLC v. Travis C. Mickle, Ph.D., et al., No. 10-00434 (W.D. Va.)
  • Johnson Matthey Inc. v. Noven Pharmaceuticals, Inc. and Shire U.S. Inc., No. 07-260 (E.D. Tex.)
  • Pharmaceutical Resources, Inc. et al. v. Roxane Laboratories, Inc., No. 03-3357 (D.N.J.)
  • Shire Laboratories Inc. v. Barr Laboratories, Inc., No. 03-1219 (S.D.N.Y.)
  • Minnesota Mining and Manufacturing Company and Riker Laboratories, Inc. v. Alphapharm Pty. Ltd., No. 99-13 (D. Minn.)
  • Astra Aktiebolag et al. v. Andrx Pharmaceuticals, Inc., et al., No. 99-8926, et al. (S.D.N.Y.)
  • US Patent No. 7,582,727: Pharmaceutical Formulations of Bivalirudin and Processes of Making the Same
  • US Patent No. 7,598,343: Pharmaceutical Formulations of Bivalirudin and Processes of Making the Same
  • US Patent No. 7,713,928: Ready-to-use Bivalirudin Compositions
  • US Patent No. 7,803,762: Ready-to-use Bivalirudin Compositions
  • US Patent No. 7,923,453: Methods of Converting A Patient's Treatment Regimen from Intravenous Administration of An Opioid to Oral Co-administration of Morphine and Oxycodone Using A Dosing Algorithem to Provide Analgesia
  • US Patent No. 7,985,773: Enhanced Activity Alcohol-based Antimicrobial Compositions
  • US Patent No. 8,012,990: Methods of Converting A Patient's Treatment Regimen from Intravenous Administration of An Opioid to Oral Co-administration of Morphine and Oxycodone Using A Dosing Algorithem to Provide Analgesia
  • US Patent No. 8,158,152: Lyophilization Process and Products Obtained Thereby
  • US Patent No. 8,182,837: Methods and Compositions for Reducing the Risk Associated with the Administration of Opioid Analgesics in Patients with Diagnosed or Undiagnosed Respiratory Illness
  • "Patent Litigation in the United States", Panelist, Federal Circuit Bar Association International Series: London, September 25, 2017
  • "The Series' Most Challenging Globally: Injunction and Damages", Moderator, Federal Circuit Bar Association International Series: Paris, October 14, 2016
  • "Innovation Breakouts: Innovation and IP Judicial Protection", Panelist, Federal Circuit Bar Association International Series: Shanghai, October 20, 2015
  • "Challenges for Innovation in Pharma and Biotech", Panelist, Federal Circuit Bar Association International Series: Geneva, October 21, 2014
  • “The In-House Management of Inventions and Patents,” The Innovation Hub, Pretoria, South Africa, January 31 and February 1, 2013
  • “A Search for Best Practices and Challenges at the Leading Edge,” Humboldt University, Berlin, Germany, November 28, 2012
  • Kuzmich, Sandy, and Russell Garman. “TRIPS and Compulsory Licences Raising the Bar.” Life Sciences Intellectual Property Review: Conference Special, 2015, pp. 56–58.
  • Women's Leader in Law, 2013 and 2015
  • SuperLawyers® Metro Edition, 2013
  • Douglas College, Rutgers University, (B.A., Chemistry, 1981)
  • Yale University, (Ph.D., Pharmacology, 1989)
  • Fordham University, (J.D., 2001)
  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy
  • New York
  • Connecticut
  • Southern District of New York
  • Eastern District of New York
  • U.S. Court of Appeals for the Federal Circuit
  • Court of International Trade
  • Registered to practice before the U.S. Patent and Trademark Office
  • Connecticut Bar Association
  • Federal Circuit Bar Association
  • New York Intellectual Property Association
  • Phi Beta Kappa
  • New York State Bar Association
  • American Bar Association
  • National Association of Women Lawyers

+1.212.863.2051
skuzmich@haugpartners.com

RELATED SERVICES

  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy

BAR ADMISSIONS

  • New York
  • Connecticut
  • Southern District of New York
  • Eastern District of New York
  • U.S. Court of Appeals for the Federal Circuit
  • Court of International Trade
  • Registered to practice before the U.S. Patent and Trademark Office

Haug Partners LLP
745 Fifth Avenue, 10th Floor,
New York, NY 10151
+1.212.588.0800
haugpartners.com

Sandy Kuzmich

Partner

HIGHLIGHT

With practical experience in the pharmaceutical sector, together with expertise in patent procurement and defense, Dr. Kuzmich appreciates and strategically manages the complex intellectual property issues that are critical to pharmaceutical and biotechnology clients.

OVERVIEW

Dr. Kuzmich serves as the co-chair of the firm’s Life Sciences practice group. Her practice focuses on patent litigation and strategic intellectual property counseling in the areas of pharmaceuticals, chemicals, and biotechnology. Recognizing that product life-cycle management is continuous and dynamic, she develops, manages, and protects diverse patent portfolios, taking into consideration a client’s immediate and long-term business objectives. Her extensive experience in pharmaceutical patent litigation allows her to offer a distinctive approach to protecting and maximizing the value of intellectual property assets. She specializes in counseling clients on how to obtain strong and diverse intellectual property protection on pharmaceuticals and biological products during early research, and how to expand and defend that protection throughout development, product launch, and beyond.

Upon completion of her graduate degree in pharmacology, Dr. Kuzmich became a post-doctoral research associate with the Fox Chase Cancer Center where she investigated mechanisms of anti-cancer drug resistance. She spent several years in the private pharmaceutical sector, managing departments in the U.S. in the areas of drug metabolism and pharmacokinetics, and also collaborating with Asian and European counterparts to coordinate worldwide regulatory submissions.

Dr. Kuzmich serves on the Board of Directors for the Federal Circuit Bar Association, which includes being a frequent lecturer at various international conferences throughout the year.

REPRESENTATIVE CASES

  • Bayer Healthcare LLC v. Baxalta Incorporated, Baxalta US Inc., and Nektar Therapeutics, No. 16-01122 (D. Del.)
  • Shire Development LLC, et al. v. Lupin Limited, et al., No. 16-612 (D. Md.)
  • Supernus Pharmaceuticals, Inc. v. Actavis, Inc., et al., No. 14-06102 (D.N.J.)
  • Shire LLC v. Travis C. Mickle, Ph.D., et al., No. 10-00434 (W.D. Va.)
  • Johnson Matthey Inc. v. Noven Pharmaceuticals, Inc. and Shire U.S. Inc., No. 07-260 (E.D. Tex.)
  • Pharmaceutical Resources, Inc. et al. v. Roxane Laboratories, Inc., No. 03-3357 (D.N.J.)
  • Shire Laboratories Inc. v. Barr Laboratories, Inc., No. 03-1219 (S.D.N.Y.)
  • Minnesota Mining and Manufacturing Company and Riker Laboratories, Inc. v. Alphapharm Pty. Ltd., No. 99-13 (D. Minn.)
  • Astra Aktiebolag et al. v. Andrx Pharmaceuticals, Inc., et al., No. 99-8926, et al. (S.D.N.Y.)

REPRESENTATIVE PATENTS

  • US Patent No. 7,582,727: Pharmaceutical Formulations of Bivalirudin and Processes of Making the Same
  • US Patent No. 7,598,343: Pharmaceutical Formulations of Bivalirudin and Processes of Making the Same
  • US Patent No. 7,713,928: Ready-to-use Bivalirudin Compositions
  • US Patent No. 7,803,762: Ready-to-use Bivalirudin Compositions
  • US Patent No. 7,923,453: Methods of Converting A Patient's Treatment Regimen from Intravenous Administration of An Opioid to Oral Co-administration of Morphine and Oxycodone Using A Dosing Algorithem to Provide Analgesia
  • US Patent No. 7,985,773: Enhanced Activity Alcohol-based Antimicrobial Compositions
  • US Patent No. 8,012,990: Methods of Converting A Patient's Treatment Regimen from Intravenous Administration of An Opioid to Oral Co-administration of Morphine and Oxycodone Using A Dosing Algorithem to Provide Analgesia
  • US Patent No. 8,158,152: Lyophilization Process and Products Obtained Thereby
  • US Patent No. 8,182,837: Methods and Compositions for Reducing the Risk Associated with the Administration of Opioid Analgesics in Patients with Diagnosed or Undiagnosed Respiratory Illness

SPEAKING ENGAGEMENTS

  • "Patent Litigation in the United States", Panelist, Federal Circuit Bar Association International Series: London, September 25, 2017
  • "The Series' Most Challenging Globally: Injunction and Damages", Moderator, Federal Circuit Bar Association International Series: Paris, October 14, 2016
  • "Innovation Breakouts: Innovation and IP Judicial Protection", Panelist, Federal Circuit Bar Association International Series: Shanghai, October 20, 2015
  • "Challenges for Innovation in Pharma and Biotech", Panelist, Federal Circuit Bar Association International Series: Geneva, October 21, 2014
  • “The In-House Management of Inventions and Patents,” The Innovation Hub, Pretoria, South Africa, January 31 and February 1, 2013
  • “A Search for Best Practices and Challenges at the Leading Edge,” Humboldt University, Berlin, Germany, November 28, 2012

PUBLICATIONS

  • Kuzmich, Sandy, and Russell Garman. “TRIPS and Compulsory Licences Raising the Bar.” Life Sciences Intellectual Property Review: Conference Special, 2015, pp. 56–58.

AWARDS

  • Women's Leader in Law, 2013 and 2015
  • SuperLawyers® Metro Edition, 2013

EDUCATION

  • Douglas College, Rutgers University, (B.A., Chemistry, 1981)
  • Yale University, (Ph.D., Pharmacology, 1989)
  • Fordham University, (J.D., 2001)

BAR ADMISSIONS

  • New York
  • Connecticut
  • Southern District of New York
  • Eastern District of New York
  • U.S. Court of Appeals for the Federal Circuit
  • Court of International Trade
  • Registered to practice before the U.S. Patent and Trademark Office

MEMBERSHIPS

  • Connecticut Bar Association
  • Federal Circuit Bar Association
  • New York Intellectual Property Association
  • Phi Beta Kappa
  • New York State Bar Association
  • American Bar Association
  • National Association of Women Lawyers